It is important to have a clinical packaging strategy that can successfully manage the supply of your expensive drug product throughout the duration of clinical testing. To do this, sponsor companies must balance control of the drug supply with control of shipping costs. Achieving this requires maximizing the amount of drug available for distribution while minimizing overages across clinical trial sites. 

The following six strategies can be used to find balance; nevertheless, they all require the support of a trusted clinical packager. Without this valuable insight, a company could experience a costly interruption or extended delay and, as a result, a devastating impact on its timeline to commercialization.